Webcapture from a recent training course (Nov 2020) held at the EBI (European Institute of Bioinformatics) that includes Phyre – open to academia and industry
Zonder titelPress release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Zonder titelPress release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde
Zonder titelResults from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study
Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial
Award of EU-FP7 funding to Alkion BioPharma as part of TriForC consortium working on the commercialization of terpenoids
Zonder titelStudy which highlighted that Bd had been introduced into Mallorca
Report examining the likelihood of meeting the World Health Organization’s (WHO) guideline levels for air pollution (PM2.5) in the UK by 2030.
Zonder titelPASTA outputs were cited within this document